SEARCH RESULTS FOR: (薇信11008748)推特微密圈Onlyfans推荐大啵G奶御姐喵了个眯儿道具自慰炮机爆操爽晕了.dxl(37020 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

No Description
G21 SRL
610-01-140
In Commercial Distribution

  • 08058964729019 ()


  • Orthopaedic cement, antimicrobial
Contains VT601US(ES,VS×2), 4 of cryotopUSs(Green)and Repro Plate
KITAZATO CORPORATION
VT601US-TOP(G)
In Commercial Distribution

  • 24582231462616 ()
  • 14582231462596 ()


  • IVF medium kit
T-MAT G/RA 50SH 8x10in film
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution

  • 60889978453931 ()
  • 40889978453937 ()
  • 00889978453939 ()
8453938

  • Dental x-ray film, screen
T-MAT G/RA Film 100SH 15x30cm
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution

  • 60889976468463 ()
  • 40889976468469 ()
  • 00889976468461 ()
6468466

  • Dental x-ray film, screen
T-MAT G/RA Film 50SH 12.7x30.5cm
CARESTREAM HEALTH, INC.
T-MAT G/RA
Not in Commercial Distribution

  • 60889976468456 ()
  • 40889976468452 ()
  • 00889976468454 ()
6468458

  • Dental x-ray film, screen
T-MAT G/RA 50SH 12.7x30.5cm film
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution

  • 60889971987624 ()
  • 40889971987620 ()
  • 00889971987622 ()
1987627

  • Dental x-ray film, screen
T-MAT G/RA 50SH 15x30cm film
CARESTREAM HEALTH, INC.
T-MAT G/RA
In Commercial Distribution

  • 60889971869081 ()
  • 40889971869087 ()
  • 00889971869089 ()
1869080

  • Dental x-ray film, screen
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft. CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate. By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture. By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation. The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection. CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-06
In Commercial Distribution

  • 07350055430530 ()

  • Total Volume: 5 Milliliter


  • Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft. CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate. By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing CERAMENT G can also reduce the likelihood of infection subsequent to an open fracture. By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation. The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection. CERAMENT G may be implanted by an injectable system. In bone infection, CERAMENT G can also be inserted as pre-set beads.
Bone Support AB
A0535-05
In Commercial Distribution

  • 07350055430523 ()

  • Total Volume: 10 Milliliter


  • Bone matrix implant, synthetic, antimicrobial
CERAMENT G is an implantable bone void filler (device/ drug combination product) indicated for use as an adjunct to systemic antibiotic therapy and surgical debridement (standard treatment approach to a bone infection) where there is a need for supplemental bone graft. CERAMENT G combines gentamicin sulfate with a bone void filler, consisting of hydroxyapatite and calcium sulfate. By eluting gentamicin, CERAMENT G can reduce the recurrence of chronic osteomyelitis from gentamicin-sensitive microorganisms in order to protect bone healing. By combining calcium sulfate and hydroxyapatite, a balance is achieved between implant resorption rate and bone remodeling rate. Calcium sulfate acts as a resorbable carrier for hydroxyapatite. Hydroxyapatite has a slow resorption rate and high osteoconductivity providing a scaffold for new bone generation. The use of CERAMENT G eliminates the need to harvest autologous bone, thereby avoiding donor site morbidity (e.g., pain, infection, etc.) in patients with a diagnosed infection. CERAMENT G may be implanted by an injectable system or inserted as pre-set beads.
Bone Support AB
A0450-11
In Commercial Distribution

  • 07350055430394 ()

  • Total Volume: 5 Milliliter


  • Bone matrix implant, synthetic, antimicrobial
< 1 ... 281 282 283 284 285 ... 1000 >